New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 15, 2012
05:55 EDTCMRG, CMRG, CYBX, CYBX, FL, FL, HIBB, HIBB, CTC, CTC, SJM, SJM, SIRO, SIROCompanies reporting Before the Market Open on Friday, November 16
Notable companies reporting before the opening bell on Friday include Casual Male Retail Group (CMRG), Cyberonics(CYBX), Foot Locker (FL), Hibbett Sports (HIBB), IFM Investment (CTC), J. M. Smucker (SJM), and Sirona Dental Systems (SIRO).
News For CMRG;CYBX;FL;HIBB;CTC;SJM;SIRO From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
December 19, 2014
16:31 EDTFLOn The Fly: Closing Wrap
Subscribe for More Information
12:27 EDTFLOn The Fly: Midday Wrap
Subscribe for More Information
11:53 EDTFLFoot Locker heads lower with peers, levels to watch
Subscribe for More Information
10:39 EDTFLNike leads footwear space lower after futures growth slows
Subscribe for More Information
10:02 EDTFLFoot Locker downgraded to Underperform from Neutral at BofA/Merrill
Subscribe for More Information
December 10, 2014
17:07 EDTSJMJ.M. Smucker announces price increases on K-cup packs
The J. M. Smucker Company announced that it is increasing the list price on its K-Cup packs sold in the United States under the Folgers, Folgers Gourmet Selections, Cafe Bustelo, and Millstone brand names. Prices will increase an average of 8%. The price increase, which will be effective on January 5, 2015, is in response to sustained increases in costs.
December 9, 2014
07:08 EDTCTCSouFun announces termination of strategic cooperation with IFM Investments
Subscribe for More Information
December 8, 2014
11:51 EDTCYBXCyberonics reports new results from E-36, E-37 studies
Cyberonics announced new results from two multi-site clinical studies of the AspireSR generator, E-36 and E-37, at the AES Annual Meeting in Seattle, Washington. Investigators presented results from the European E-36 study and the U.S. E-37 study, which assessed the acute impact of the AspireSR generator on seizure duration and termination, as well as the long-term evaluation of safety, clinical benefit of the automatic stimulation feature, and quality of life. Assessments of seizure severity and quality of life were made using validated scales scored by patients and physicians. The acute impact of the AspireSR generator on seizure duration and termination was evaluated during the Epilepsy Monitoring Unit stay period experienced by all patients in both studies. Seizure activity was recorded using concurrent video-EEG and ECG monitoring. Patients in both studies experienced termination of seizures as well as reduced seizure duration during automatic stimulation compared to historical controls. The AspireSR generator is currently investigational in the U.S. and not approved for commercial use. The AspireSR generator attained the CE Mark and is now available in an increasing number of European countries.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use